Correlation Between Oric Pharmaceuticals and Cronos

Can any of the company-specific risk be diversified away by investing in both Oric Pharmaceuticals and Cronos at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Oric Pharmaceuticals and Cronos into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Oric Pharmaceuticals and Cronos Group, you can compare the effects of market volatilities on Oric Pharmaceuticals and Cronos and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Oric Pharmaceuticals with a short position of Cronos. Check out your portfolio center. Please also check ongoing floating volatility patterns of Oric Pharmaceuticals and Cronos.

Diversification Opportunities for Oric Pharmaceuticals and Cronos

0.43

Correlation Coefficient

Oric Pharmaceuticals  Cronos

Very weak diversification

The 3 months correlation between Oric and Cronos is 0.43. Overlapping area represents the amount of risk that can be diversified away by holding Oric Pharmaceuticals and Cronos Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cronos Group and Oric Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Oric Pharmaceuticals are associated (or correlated) with Cronos. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cronos Group has no effect on the direction of Oric Pharmaceuticals i.e., Oric Pharmaceuticals and Cronos go up and down completely randomly.

Pair Corralation between Oric Pharmaceuticals and Cronos

Given the investment horizon of 90 days Oric Pharmaceuticals is expected to under-perform the Cronos. In addition to that, Oric Pharmaceuticals is 1.75 times more volatile than Cronos Group. It trades about -0.24 of its total potential returns per unit of risk. Cronos Group is currently generating about 0.0 per unit of volatility. If you would invest  203.00  in Cronos Group on October 4, 2024 and sell it today you would lose (1.00) from holding Cronos Group or give up 0.49% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	95.45%
Values	Daily Returns

Oric Pharmaceuticals  vs.  Cronos Group

Oric Pharmaceuticals

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Oric Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's forward indicators remain sound and the latest tumult on Wall Street may also be a sign of longer-term gains for the firm shareholders.

Cronos Group

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Cronos Group has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest inconsistent performance, the Stock's basic indicators remain healthy and the recent disarray on Wall Street may also be a sign of long period gains for the firm investors.

Pair Trading with Oric Pharmaceuticals and Cronos

The main advantage of trading using opposite Oric Pharmaceuticals and Cronos positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Oric Pharmaceuticals position performs unexpectedly, Cronos can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cronos will offset losses from the drop in Cronos' long position.

The idea behind Oric Pharmaceuticals and Cronos Group pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.